Filter browse results

Total results with these characteristics: 73

Page 1 of 2
Announcement | November 03, 2014
PATH to collaborate with GlaxoSmithKline to develop a test critical to malaria care

New diagnostics for a common enzyme deficiency will bolster malaria elimination efforts

Press release | November 02, 2014
New malaria vaccines to prevent infection and block transmission get a shot in the arm

Grant from Gates Foundation to PATH Malaria Vaccine Initiative

Press release | August 12, 2014
First antimalarial treatments produced with semisynthetic artemisinin enter market

First shipment marks a critical step in improving access to treatment worldwide

Announcement | June 03, 2014
PATH Malaria Vaccine Initiative names new director of research & development

Dr. Rick King to lead work in transmission-blocking vaccines, evaluation technology

Announcement | April 17, 2014
PATH marks World Malaria Day 2014

Events in Seattle and Berkeley, California, highlight progress and commitment toward eliminating malaria

Announcement | March 27, 2014
PATH receives funding to build new tools in the fight against malaria

Point-of-care diagnostic test seeks to improve management of P. vivax malaria

Announcement | November 08, 2013
Join PATH at the American Society of Tropical Medicine and Hygiene conference

PATH staff will highlight our work to leverage new approaches and tools in the fight against malaria

Press release | October 22, 2013
PATH Malaria Vaccine Initiative names new director

Ashley Birkett, PhD, to lead key product development program at PATH

Press release | October 07, 2013
Malaria vaccine candidate reduces disease over 18 months of follow-up in late-stage study of more than 15,000 infants and young children
Announcement | October 06, 2013
Join PATH at the Pan-African Multisectoral Initiative on Malaria conference

PATH staff will highlight our work in malaria control, treatment, and vaccine development

Announcement | August 27, 2013
New PATH partnership will advance solutions for diarrhea and malaria

UK government is funding nine innovative partnerships to address deadly diseases

Press release | May 10, 2013
Semisynthetic artemisinin achieves WHO prequalification

First non-plant-derived source of a key ingredient in the top malaria drug will increase access to treatment

Press release | April 11, 2013
Sanofi and PATH announce the launch of large-scale production of semisynthetic artemisinin against malaria

A pivotal milestone in the fight against malaria

Press release | January 07, 2013
PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals partner to accelerate development of malaria vaccines and innovative delivery technologies

Follow-on agreement will lead to clinical trials

Press release | November 29, 2012
PATH, Medical Care Development International, Population Services International, and Save the Children receive USAID award to expand malaria diagnosis and treatment globally
Press release | November 12, 2012
PATH’s Kent Campbell honored for lifetime achievement in the fight against malaria

Campbell awarded American Society of Tropical Medicine and Hygiene prestigious LePrince Medal

Press release | November 09, 2012
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants

Results from ongoing Phase III clinical trial announced

Press release | August 14, 2012
PATH Malaria Vaccine Initiative names eminent malaria scientists and vaccinologists to advisory council
Announcement | June 07, 2012
President’s Malaria Initiative evaluated

Briefing on successes of first five years, how to sustain progress

Announcement | April 20, 2012
PATH recognizes World Malaria Day 2012

Events in Seattle and Washington, DC, highlight progress toward ending malaria deaths

Announcement | April 18, 2012
Live webcast on new directions in malaria

PATH leaders discuss future directions in development of vaccines, prevention and control, and drug treatments

Press release | March 01, 2012
PATH Malaria Vaccine Initiative announces new leader
Announcement | December 09, 2011
Advocating for malaria control and prevention

Congressional hearing highlights progress against malaria and challenges that remain

Press release | October 18, 2011
First results from ongoing Phase III trial show malaria vaccine candidate, RTS,S* reduces the risk of malaria by half in African children aged 5 to 17 months

Half the world’s population is at risk of malaria which is responsible for close to 800,000 deaths each year, most of whom are children under five in sub-Saharan Africa

Announcement | October 17, 2011
Many countries poised to end malaria

Nearly a third of affected countries may be malaria-free within ten years

Announcement | October 06, 2011
Experts see an end to malaria in Africa

Existing tools make eliminating malaria infections an achievable goal

Announcement | September 12, 2011
Malaria deaths drop 38 percent in a decade

New report co-authored by PATH highlights roles of global partnerships, increased funding

Announcement | May 16, 2011
Fighting malaria in the workplace

Investing in malaria control pays off for companies and their employees

Announcement | April 13, 2011
New tools to fight malaria

We’ve made progress against malaria, but it will take innovation to eradicate the disease

Press release | December 14, 2010
The PATH Malaria Vaccine Initiative, Merck, and NYU Langone Medical Center collaborate to research potential malaria vaccine
Announcement | November 01, 2010
New article credits malaria control for recent declines in African child mortality
Announcement | October 20, 2010
Capitol Hill briefing focuses on the role of African scientists in the fight against malaria
Press release | September 14, 2010
New report shows investment in malaria prevention paying off: hundreds of thousands of children’s lives saved
Press release | July 14, 2010
Researchers, health experts from five African countries convene to support advocacy for malaria vaccines
Announcement | March 18, 2010
Newly launched malaria series benchmarks global progress

The first report in the series, co-authored by MACEPA at PATH, addresses malaria control funding in sub-Saharan Africa

Announcement | January 20, 2010
PATH welcomes positive steps on price, donations for GlaxoSmithKline’s RTS,S malaria vaccine candidate
Press release | January 15, 2010
First steps taken toward the development of a malaria transmission-blocking vaccine
Announcement | December 15, 2009
Zambia progress featured in world malaria report
Announcement | December 02, 2009
New tools are needed for the fight against malaria, experts tell Congress

In a briefing co-sponsored by PATH, malaria experts discuss research and development to control and eliminate malaria

Press release | November 03, 2009
World’s largest malaria vaccine trial now underway in seven African countries
Page 1 of 2